FDA Inspection
Medline Industries, Inc.Medline Industries, Inc. – FDA Inspection, Jan 16, 2025
Record Details
This FDA Inspection record concerns Medline Industries, Inc., with an inspection on January 16, 2025, issued by the Chicago District Office, covering human drugs.
View Company Profile
ID · 334aea2b-b507-44ea-8a17-2ba7a435c686
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1258730
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
6- 21 CFR 314.81(b)(1)(ii)Contamination, chemical or physical change, deterioration
- 21 CFR 211.198(b)(2)Complaint Investigation/Follow-Up Findings
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.198(a)Complaint Handling Procedure
- 21 CFR 211.113(a)Procedures for non-sterile drug products
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Medline Industries, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| October 14, 2025 | OAI | Drug Quality Assurance | |
| March 17, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Medline Industries, Inc.
- FDA Inspection 1297688 - 2025-10-14
- FDA Inspection 970052 - 2016-03-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.